Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5B
| $7.91M | ﹤0.01% |
95,289
-3,262
| -3% | -$262K |
|
2102
Prothena Corp
PRTA
$436M
| $7.9M | ﹤0.01% |
318,905
+5,675
| +2% | +$169K |
|
2103
ZIM Integrated Shipping Services
ZIM
$3.04B
| $7.89M | ﹤0.01% |
779,629
+267,526
| +52% | +$3.25M |
|
2104
Lucid Motors
LCID
$3B
| $7.88M | ﹤0.01% |
276,630
+3,747
| +1% | +$119K |
|
2105
iShares Russell Mid-Cap ETF
IWR
$56.3B
| $7.87M | ﹤0.01% |
93,627
-42,536
| -31% | -$3.37M |
|
2106
QuinStreet
QNST
$897M
| $7.86M | ﹤0.01% |
445,328
+14,252
| +3% | +$203K |
|
2107
indie Semiconductor
INDI
$716M
| $7.82M | ﹤0.01% |
1,104,060
+42,479
| +4% | +$288K |
|
2108
Alkami Technology
ALKT
$2.01B
| $7.81M | ﹤0.01% |
317,664
+7,883
| +3% | +$194K |
|
2109
NCR Atleos
NATL
$3.44B
| $7.8M | ﹤0.01% |
395,162
-93,854
| -19% | -$2.01M |
|
2110
Middlesex Water
MSEX
$1.07B
| $7.79M | ﹤0.01% |
148,406
+2,365
| +2% | +$131K |
|
2111
Hertz
HTZ
$483M
| $7.78M | ﹤0.01% |
993,585
+235,402
| +31% | +$1.93M |
|
2112
Atlas Energy Solutions
AESI
$1.37B
| $7.77M | ﹤0.01% |
343,497
+7,173
| +2% | +$134K |
|
2113
F&G Annuities & Life
FG
$3.85B
| $7.75M | ﹤0.01% |
191,226
+3,636
| +2% | +$152K |
|
|
EFC
2114
Ellington Financial
EFC
$1.67B
| $7.72M | ﹤0.01% |
653,961
-4,437
| -0.7% | -$53.3K |
|
|
UDMY
2115
DELISTED
Udemy
UDMY
| $7.7M | ﹤0.01% |
701,468
+11,700
| +2% | +$145K |
|
2116
MacroGenics
MGNX
$243M
| $7.7M | ﹤0.01% |
522,946
-310,554
| -37% | -$4.69M |
|
2117
Lemonade
LMND
$4.1B
| $7.69M | ﹤0.01% |
468,904
+9,080
| +2% | +$153K |
|
2118
Transcat
TRNS
$838M
| $7.68M | ﹤0.01% |
68,919
+580
| +0.8% | +$61.4K |
|
2119
Insteel Industries
IIIN
$602M
| $7.67M | ﹤0.01% |
200,735
+40,096
| +25% | +$1.43M |
|
2120
Mercantile Bank Corp
MBWM
$1.05B
| $7.64M | ﹤0.01% |
198,416
-625
| -0.3% | -$23.8K |
|
|
HAPN
2121
Happen Inc
HAPN
$2.36B
| $7.63M | ﹤0.01% |
868,204
+19,889
| +2% | +$167K |
|
2122
Lufax Holding
LU
$1.31B
| $7.6M | ﹤0.01% |
1,801,810
+414,507
| +30% | +$1.16M |
|
2123
Zumiez
ZUMZ
$332M
| $7.6M | ﹤0.01% |
500,451
+42,671
| +9% | +$728K |
|
2124
Relay Therapeutics
RLAY
$4.09B
| $7.57M | ﹤0.01% |
912,157
+34,344
| +4% | +$335K |
|
|
DAWN
2125
DELISTED
Day One Biopharmaceuticals
DAWN
| $7.56M | ﹤0.01% |
457,652
+4,718
| +1% | +$70.6K |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.